For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

King's College London

Return to search Previous output Next output
Output 21 of 502 in the submission
Article title

A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors

Type
D - Journal article
Title of journal
Clinical Cancer Research
Article number
-
Volume number
14
Issue number
7
First page of article
2075
ISSN of journal
1078-0432
Year of publication
2008
URL
-
Number of additional authors
16
Additional information
-
Interdisciplinary
-
Cross-referral requested
-
Research group
B - Cancer
Citation count
67
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-